Lalwani Nikhil — SEC insider filings
SEC reporting owner CIK 1822629. 34 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 34 filings on record, filed 2020-09-10 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 7,224 shares, $199,997 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 14 legs across 10 filings — 297,249 shares, $20,735,609 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: sale of 56,960 shares @ $85.93 ($4,894,573) in ANI PHARMACEUTICALS INC, filed 2025-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO, Director | 34 | 1 leg · 7,224 sh · $199,997 | 14 legs · 297,249 sh · $20,735,609 | 36 |
Insider filings — Lalwani Nikhil
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 1,318 @ $71.40 · Sale (S): 4,082 @ $71.16 | EDGAR |
| 2026-10-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 5,400 @ $71.89 | EDGAR |
| 2026-09-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 5,400 @ $71 | EDGAR |
| 2026-08-26 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 5,400 @ $74.30 | EDGAR |
| 2026-05-13 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 55,000 @ $77.57 | EDGAR |
| 2026-03-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,060 @ $74.04 | EDGAR |
| 2026-03-02 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 75,592 @ $77.15 · Tax withholding (F): 12,217 @ $73.90 | EDGAR |
| 2026-02-17 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 11,688 @ $76.70 · Tax withholding (F): 10,298 @ $77.36 | EDGAR |
| 2026-02-13 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 30,659 @ $76.25 | EDGAR |
| 2025-08-14 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 56,960 @ $85.93 | EDGAR |
| 2025-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,455 @ $64.26 | EDGAR |
| 2025-03-14 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,060 @ $60.62 | EDGAR |
| 2025-03-04 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 12,216 @ $61.89 | EDGAR |
| 2025-02-18 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 91,399 @ $0 · Grant/award (A): 60,932 @ $0 · Tax withholding (F): 7,799 @ $58.92 | EDGAR |
| 2024-11-27 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Option exercise (M): 30,000 @ $29 · Sale (S): 30,000 @ $57.95 · Sale (S): 3,481 @ $58.30 · Option exercise (M): 30,000 (derivative) @ $29 | EDGAR |
| 2024-09-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 3,646 @ $60.51 | EDGAR |
| 2024-05-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 16,669 @ $66.10 | EDGAR |
| 2024-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,455 @ $69.58 | EDGAR |
| 2024-03-08 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 28,965 @ $65.52 · Tax withholding (F): 17,060 @ $66.71 · Sale (S): 16,292 @ $67.13 | EDGAR |
| 2024-03-01 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 10,014 @ $67.67 | EDGAR |
| 2024-02-16 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 80,530 @ $0 · Grant/award (A): 53,686 @ $0 | EDGAR |
| 2023-09-11 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 3,646 @ $61.94 | EDGAR |
| 2023-08-15 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Sale (S): 56,666 @ $57.75 · Option exercise (M): 11,616 @ $29 · Sale (S): 11,616 @ $61.13 · Option exercise (M): 11,616 (derivative) @ $29 | EDGAR |
| 2023-04-04 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 95,530 @ $0 · Grant/award (A): 63,686 @ $0 | EDGAR |
| 2023-03-27 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,455 @ $37.82 | EDGAR |
| 2023-03-09 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 9,397 @ $44.23 · Tax withholding (F): 4,265 @ $44.23 | EDGAR |
| 2022-09-12 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 3,646 @ $37.61 | EDGAR |
| 2022-04-29 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 33,352 @ $0 | EDGAR |
| 2022-03-28 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 100,055 @ $0 | EDGAR |
| 2022-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 17,454 @ $27.03 | EDGAR |
| 2022-03-23 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Purchase (P): 7,224 @ $27.69 | EDGAR |
| 2021-09-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Tax withholding (F): 2,577 @ $28.20 | EDGAR |
| 2021-03-25 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 136,495 @ $0 | EDGAR |
| 2020-09-10 | 4 | ANI PHARMACEUTICALS INC (ANIP) | Grant/award (A): 28,508 @ $0 · Grant/award (A): 179,643 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1822629 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs